Authors:
DINGEMANSE J
WALLNOFER A
GIESCHKE R
GUENTERT T
AMREIN R
Citation: J. Dingemanse et al., PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN FLUOXETINE AND MOCLOBEMIDE IN THE INVESTIGATION OF DEVELOPMENT OF THE SEROTONIN SYNDROME, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 403-413
Citation: I. Binet et al., RENAL HEMODYNAMIC-EFFECTS OF BOSENTAN, AN ENDOTHELIN ANTAGONIST, AND INTERACTION WITH CYCLOSPORINE-A - A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY, Kidney international, 52(5), 1997, pp. 1426-1427
Citation: I. Binet et al., RENAL HEMODYNAMIC-EFFECTS OF AN ENDOTHELIN ANTAGONIST BOSENTAN, AND INTERACTION WITH CYCLOSPORINE-A - A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1643-1643
Authors:
DINGEMANSE J
KNEER J
WALLNOFER A
KETTLER R
ZURCHER G
KOULU M
KORN A
Citation: J. Dingemanse et al., PHARMACOKINETIC-PHARMACODYNAMIC INTERACTIONS BETWEEN 2 SELECTIVE MONOAMINE-OXIDASE INHIBITORS - MOCLOBEMIDE AND SELEGILINE, Clinical neuropharmacology, 19(5), 1996, pp. 399-414
Authors:
MAY A
GIJSMAN HJ
WALLNOFER A
JONES R
DIENER HC
FERRARI MD
Citation: A. May et al., ENDOTHELIN ANTAGONIST BOSENTAN BLOCKS NEUROGENIC INFLAMMATION, BUT ISNOT EFFECTIVE IN ABORTING MIGRAINE ATTACKS, Pain, 67(2-3), 1996, pp. 375-378
Authors:
WALLNOFER A
GUENTERT TW
ECKERNAS SA
DINGEMANSE J
Citation: A. Wallnofer et al., MOCLOBEMIDE AND FLUVOXAMINE COADMINISTRATION - A PROSPECTIVE-STUDY INHEALTHY-VOLUNTEERS TO INVESTIGATE THE POTENTIAL DEVELOPMENT OF THE SEROTONIN SYNDROME, Human psychopharmacology, 10(1), 1995, pp. 25-31
Authors:
WOLF C
WALLNOFER A
WALDHOR T
VUTUC C
MEISINGER V
RUDIGER HW
Citation: C. Wolf et al., EFFECT OF LEAD ON BLOOD-PRESSURE IN OCCUPATIONALLY NONEXPOSED MEN, American journal of industrial medicine, 27(6), 1995, pp. 897-903